Product logins

Find logins to all Clarivate products below.


Open Surgery Instruments | Market Insights | Asia Pacific (Supplemental) | 2021

Although it will be negatively impacted in the short term by the COVID-19 pandemic, the Asia Pacific open surgery instrument market will grow moderately through 2029. Emerging economies will be major centers of growth due to their improving health care infrastructure and promising economic and demographic landscapes. Additionally, the mature markets will grow, primarily as a result of demand for innovative and premium-priced products, especially in the direct energy device segment.

This Medtech 360 Report provides high-level market metrics for the open surgery instrument market in Asia Pacific, including country-level data for major countries and aggregate data for the rest of Asia Pacific, across a 10-year period.

Related Medtech Insights Reports

Report
Biosurgical Agents – Market Insights – Asia Pacific (Supplemental)
The biosurgical agent market in the Asia-Pacific will experience modest growth through 2033. This growth will be fueled by an increasing number of surgical interventions that require biosurgical…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Asia Pacific
The GI endoscopy device market will continue to grow moderately throughout the forecast period, supported by the high incidence of gastric cancer and CRC cases in the region. Growth will be…
Report
Dental Implants – Market Insights – Asia Pacific
The Asia Pacific dental implant market will grow strongly over the forecast period. Demand for dental implants is rising, driven by the aging population, increased oral health awareness, and higher…
Report
Neurovascular Devices – Market Insights – Asia Pacific
The Asia Pacific neurovascular device market will grow strongly through the forecast period, driven by various factors such as rising procedure volumes, product launches, and increasing…
Report
Large-Joint Reconstructive Implants – Market Insights – Asia Pacific
The Asia Pacific large-joint reconstructive implant market is experiencing moderate growth driven by an increasing number of elective procedures, a rising elderly population affected by arthritis…